Galibra Neuroscience, Inc.
Biotechnology company · Chestnut Hill, Massachusetts, United States
Galibra Neuroscience, Inc. is a biotechnology company headquartered in Chestnut Hill, Massachusetts, United States. Its earliest recorded incorporation is in 2023. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $500,000 in total, most recently in 2025. It has reported private securities offerings to the US SEC, most recently $100,000 sold in a notice filed in 2024.
Galibra Neuroscience at a glance
What does Galibra Neuroscience do?
US government research funding
1 SBIR/STTR small-business research award from US health agencies, $500,000 in total (2025). NIH funding came from the National Institute of Neurological Disorders and Stroke.
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $100,000 sold (2024).
Frequently asked questions about Galibra Neuroscience
Where is Galibra Neuroscience headquartered?
Galibra Neuroscience, Inc. is headquartered in Chestnut Hill, Massachusetts, United States.
What does Galibra Neuroscience do?
Galibra Neuroscience, Inc. is a biotechnology company.
When was Galibra Neuroscience founded?
The earliest incorporation on record for Galibra Neuroscience, Inc. is in 2023, according to public company registers.
Similar companies
- PhenoSolve LLCChestnut Hill, Massachusetts, United States
- Axelyf, Inc.Chestnut Hill, Massachusetts, United States
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences